5 - How to Change the Reporting of Microbiology Results to Improve Antibiotic Prescribing Section: 1 Presentation 1 Certificate 1 Survey
92 - Novel Strategies to Help Antibiotics to Play their Role Section: 1 Presentation 1 Certificate 1 Survey
93 - Novel Vaccines: From Basic Research Through Clinical Development Section: 1 Presentation 1 Certificate 1 Survey
103 - The Heart of It All: Update on Endocarditis 2016 Section: 1 Presentation 1 Certificate 1 Survey
115 - Antimicrobial Breakpoints: Time for a Single CAST? Section: 1 Presentation 1 Certificate 1 Survey
128 - New insights on Emerging Resistance Mechanisms in Gram-negatives Section: 1 Presentation 1 Certificate 1 Survey
133 - Decreased Antibiotic Efficacy in Renal Impairment: Are We Getting the Dose Wrong? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) Section: 1 Presentation 1 Certificate 1 Survey
134 - Fresh Approaches to Antibiotic Drug Discovery: Breaking from Convention Section: 1 Presentation 1 Certificate 1 Survey
207 - Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance in Gram-positive Bacteria Section: 1 Presentation 1 Certificate 1 Survey
209 - Case Management of Tropical Infectious Diseases and Travel Medicine (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) Section: 1 Presentation 1 Certificate 1 Survey
232 - How to Use Behavioral Theories to Design an Effective Antimicrobial Stewardship Program Section: 1 Presentation 1 Certificate 1 Survey
247 - Innovations and Challenges in Pharmacokinetics/Pharmacodynamics (PK/PD) Section: 1 Presentation 1 Certificate 1 Survey
257 - Encephalitis: What Is New? (Supported Jointly with the Société de Pathologie Infectieuse de Langue Française (SPILF)) Section: 1 Presentation 1 Certificate 1 Survey
261 - Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG)) Section: 1 Presentation 1 Certificate 1 Survey
263 - Pneumonia Etiology of Infants in Resource Limited Settings: 2016 Update on Diagnostics, Prevention and Treatment Section: 1 Presentation 1 Certificate 1 Survey
267 - What’s in the Pipeline? Recently Approved and Experimental Antimicrobial Agents Section: 1 Presentation
338 - Attacking the MDR Puzzle from the Other Direction: Non-Antibiotic Approaches to Treating Bacterial Infections Section: 1 Presentation 1 Certificate 1 Survey
343 - Environmental Enteropathy During Infancy: Malnutrition and Growth Stunting (Supported jointly by the Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) Section: 1 Presentation 1 Certificate 1 Survey
358 - Who Paves the Way for Fungi: Genes or Doctors? (Organized in Cooperation with the lmmunocompromised Host Society (ICHS)) Section: 1 Presentation 1 Certificate 1 Survey
364 - From Phenotype to Molecular Detection: The Case of Carbapenemases Section: 1 Presentation 1 Certificate 1 Survey
366 - PK/PD Optimization against Carbapenamase Producing Bacteria Section: 1 Presentation 1 Certificate 1 Survey
374 - RNA Modulation and Cellular Signals in Antimicrobial Resistance Section: 1 Presentation 1 Certificate 1 Survey
376 - Aiming at Non-Conventional Approaches to TB Therapies (Supported Jointly by the Bill & Melinda Gates Foundation) Section: 1 Presentation 1 Certificate 1 Survey
378 - Antimicrobial Toxicodynamics (Organized in Cooperation with the International Society of Anti-Infective Pharmacology (ISAP)) Section: 1 Presentation 1 Certificate 1 Survey
437 - Staphylococcus aureus Infection Treatments: New Compounds, New Strategies Section: 1 Presentation 1 Certificate 1 Survey
445 - Tricky Choices Regarding Appropriate Antimicrobial Prescribing Section: 1 Presentation 1 Certificate 1 Survey